Urinary excretion of platinum, arsenic and selenium of cancer patients from the Antofagasta region in Chile treated with platinum-based drugs
<p>Abstract</p> <p>Background</p> <p>Arsenic exposure increases the risk of non-cancerous and cancerous diseases. In the Antofagasta region in Chile, an established relationship exists between arsenic exposure and the risk of cancer of the bladder, lung and skin. Platin...
Main Authors: | Román Domingo A, Pizarro Isabel, Rivera Lidia, Torres Carolina, Ávila Juan, Cortés Pedro, Gill Marjorie |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-04-01
|
Series: | BMC Research Notes |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1756-0500/5/207 |
Similar Items
-
Binational Arsenic Exposure Survey: Modeling Arsenic and Selenium Intake on Urinary Arsenic Biomarkers
by: Roberge, Jason Linscot
Published: (2012) -
Palladium and Platinum complexes with pyridyl thiolate selenium (IV) and (o-aminophenylthiolato) selenium (IV)
by: N.H. Buttrus, et al.
Published: (2007-04-01) -
The Evaluation Of 6 And 12 Hour Urine Collection For Assessing Proteinuriu In The Hypertensive Gravida
by: Rahimi Sherbaf F, et al.
Published: (2003-10-01) -
Estimating 24-Hour Sodium Excretion from Spot Urine Samples in Chinese Adults: Can Spot Urine Substitute 24-Hour Urine Samples?
by: Jianwei Xu, et al.
Published: (2020-03-01) -
Estimation of 24-Hour Urinary Sodium Excretion Using Spot Urine Samples
by: Moo-Yong Rhee, et al.
Published: (2014-06-01)